1 / 6

2017 National Cancer Patient Experience Survey Overview of NBT Results Published September 2018

2017 National Cancer Patient Experience Survey Overview of NBT Results Published September 2018. Carol Chapman Lead Cancer Nurse Patient Experience Group. Background. Annual survey - commenced in 2010 Aim to monitor national progress on cancer care and inform service improvements

wmartin
Télécharger la présentation

2017 National Cancer Patient Experience Survey Overview of NBT Results Published September 2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 2017 National Cancer Patient Experience SurveyOverview of NBT Results Published September 2018 Carol Chapman Lead Cancer Nurse Patient Experience Group

  2. Background • Annual survey - commenced in 2010 • Aim to monitor national progress on cancer care and inform service improvements • 110,449 eligible patients identified nationally with 69,072 competed responses (response rate of 63%) • Included all adult patients admitted as an inpatient or outpatient between April to June 2017 with a cancer related condition

  3. Reporting methodology • The CQC standard for reporting comparative performance is applied, based on calculation of “expected ranges” • Trusts/CCGs are flagged as outliers only if there is statistical evidence that their scores deviate (positively or negatively) from the range of scores that would be expected for Trusts/CCGs of the same size • Site specific results were reported only for Breast, Colorectal, Prostate, Haematological, Skin and Urological cancers • The results of tumour groups with less than 20 respondents were not reported to protect confidentiality and because uncertainty around results is too great • Brain/CNS number of respondents was 10 at NBT

  4. SWAG Overview

  5. SWAG Cancer dashboard results

  6. NBT Brain/CNS – Patients comments

More Related